The small molecule KIRA8 disrupts IRE1α-dependent growth of multiple myeloma cells in mice, and it has greater efficacy in combination with the proteasome inhibitor bortezomib or the immunomodulatory agent lenalidomide [106]. Here, ERN1 is linked to AL amyloidosis.